Related Experiment Videos
Intravitreal dexamethasone effectively reduces postoperative inflammation after vitreoretinal surgery
Kakarla V Chalam1, Sunil Malkani, Vinay A Shah
1Department of Ophthalmology, University of Florida College of Medicine, Jacksonville 32209, USA.
Summary
A single intravitreal injection of dexamethasone significantly reduces eye inflammation following vitreous surgery for proliferative diabetic retinopathy and macular pucker.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Pharmacology
Background:
- Corticosteroids are standard for managing post-vitreous surgery ocular inflammation.
- Proliferative diabetic retinopathy and macular pucker often require vitreous surgery.
Purpose of the Study:
- To assess the efficacy of a single intravitreal dexamethasone phosphate injection.
- To evaluate its impact on postoperative inflammation after vitreous surgery.
Main Methods:
- A prospective, randomized study involved 56 patients undergoing vitreous surgery.
- Patients were randomized to receive either 400 mcg intravitreal dexamethasone or no treatment.
- Aqueous cell and flare intensity were measured preoperatively and at 1, 10, and 90 days post-surgery.
Main Results:
- Preoperative inflammation levels were comparable between groups.
- The dexamethasone treatment group showed significantly lower flare intensity at 10 and 90 days (P < .05).
Conclusions:
- Intravitreal dexamethasone effectively reduces postoperative inflammation after vitreous surgery.
- It serves as a valuable adjunctive therapy for patients with proliferative diabetic retinopathy and macular pucker.